More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$37.00B
EPS
4.73
P/E ratio
15.1
Price to sales
1.4
Dividend yield
0.196%
Beta
0.76761
Previous close
$82.96
Today's open
$82.49
Day's range
$81.79 - $83.65
52 week range
$58.75 - $89.77
show more
CEO
Peter J. Arduini
Employees
54000
Headquarters
Chicago, IL
Exchange
Nasdaq Global Select
Shares outstanding
452137831
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
GE HealthCare Expands Global Research Network for Photon-Counting CT
GEHC expands its global research network for Photonova Spectra to advance photon-counting CT applications, clinical adoption and diagnostic capabilities.
Zacks Investment Research • 6 hours ago

GE HealthCare brings advanced visualization into InteleViewer to support radiology workflows
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the integration of the AW ONE ecosystem, a unified ecosystem for post processing and advanced visualization, with InteleViewer, IntelePACS' diagnostic viewer designed to support seamless radiology workflows.1 Clinicians can now launch advanced visualization and workflow automation applications in the AW ONE ecosystem directly within InteleViewer as they review and interpret images, without having to switch to a separate environmen.
Business Wire • 11 hours ago

Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
GE HealthCare's record backlog, strong Pharmaceutical Diagnostics growth and AI-powered innovations position it for long-term growth despite inflation and tariff risks.
Zacks Investment Research • Nov 17, 2026

GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expansion of its global clinical and research collaborations to advance Photonova Spectra,i the company's next-generation photon-counting CT system. Following recent global regulatory clearances, leading academic hospitals and research institutions across North America, Europe and Asia are beginning structured evaluations of Photonova Spectra to further define its clinical utility, optimize imaging protocols and explore n.
Business Wire • Nov 16, 2026

GEHC or SYK: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Nov 16, 2026

GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
GEHC's MAGNUS Neuro Alliance aims to advance neuroscience research, expand MRI applications and develop imaging biomarkers for neurological conditions.
Zacks Investment Research • Nov 13, 2026

GE HealthCare: 3 Key Takeaways for Long-Term Investors
GE HealthCare raised its full-year 2026 organic revenue guidance to 4%. The equipment backlog grew 12% year over year to $23.7 billion.
The Motley Fool • Nov 11, 2026

GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 10, 2026

GEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS
GE HealthCare expands Vscan Air's AI capabilities with Lung Guidance and AutoAS, enhancing cardiopulmonary assessments and point-of-care diagnostic support.
Zacks Investment Research • Nov 10, 2026

GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the intent to establish a collaborative research network focused on advancing neuroscience research leveraging an ultra high-gradient head-only 3.0T MR system1. The MAGNUS2 Neuro Alliance will bring together researchers and clinicians with expertise in neurology, radiology, psychiatry, oncology, and several other subject areas, to explore how high-performance MR imaging may enable new scientific questions and research approa.
Business Wire • Nov 10, 2026

¹ Disclosures

Open an M1 investment account to buy and sell GE HealthCare Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.